Low Variant Allele Frequency of TP53 as a Biomarker for PD-1/PD-L1 Inhibitors in Lung Adenocarcinoma
JOURNAL OF THORACIC ONCOLOGY（2021）
Key words
Lung adenocarcinoma, immunotherapy, Biomarker
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined